Literature DB >> 7193040

Rastelli procedure for transposition of the great arteries, ventricular septal defect, and left ventricular outflow tract obstruction. Early and late results in 41 patients (1971 to 1978).

A L Moulton, M R de Leval, F J Macartney, J F Taylor, J Stark.   

Abstract

Forty-one children with transposition of the great arteries, ventricular septal defect, and left ventricular outflow tract obstruction underwent a Rastelli operation between 1971 and 1978. A homograft valve preserved in an antibiotic solution and extended with A dacron tube was the conduit of choice. Alternatively, conduits with porcine heterografts or valves constructed from calf pericardium were used. They were positioned to the left of the aorta whenever possible. The intraventricular tunnel from the left ventricle to the aorta was constructed from Dacron velour. There were four early and seven late deaths. The last 13 consecutive patients have survived. Early deaths were related to unfavourable anatomy, conduit compression, and sepsis. Residual ventricular septal defects and postoperative infection were the main factors contributing to the late deaths.

Entities:  

Mesh:

Year:  1981        PMID: 7193040      PMCID: PMC482484          DOI: 10.1136/hrt.45.1.20

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  33 in total

1.  Reoperation after insertion of aortic homograft as a right ventricular outflow tract.

Authors:  G Merin; D C McGoon
Journal:  Ann Thorac Surg       Date:  1973-08       Impact factor: 4.330

2.  Correction of pulmonary atresia with a homograft aortic valve.

Authors:  D N Ross; J Somerville
Journal:  Lancet       Date:  1966-12-31       Impact factor: 79.321

3.  Mustard's operation for transposition of the great arteries. Review of 200 cases.

Authors:  I M Breckenridge; J Stark; R E Bonham-Carter; H Oelert; G R Graham; D J Waterston
Journal:  Lancet       Date:  1972-05-27       Impact factor: 79.321

4.  Massive calcification and obstruction in a homograft after the Rastelli procedure for transposition of great arteries.

Authors:  S C Park; W H Neches; C C Lenox; J R Zuberbuhler; H T Bahnson
Journal:  Am J Cardiol       Date:  1973-11       Impact factor: 2.778

5.  A valve-containing dacron prosthesis. Its use in restoring pulmonary artery-right ventricular continuity.

Authors:  F O Bowman; W D Hancock; J R Malm
Journal:  Arch Surg       Date:  1973-11

6.  Natural history of transpositon of the great arteries. Anatomy and birth and death characteristics.

Authors:  J Liebman; L Cullum; N B Belloc
Journal:  Circulation       Date:  1969-08       Impact factor: 29.690

7.  Repair of transposition of the great arteries of transposition of venous return. Surgical considerations and results of operation.

Authors:  G K Danielson; D D Mair; P A Ongley; R B Wallace; D C McGoon
Journal:  J Thorac Cardiovasc Surg       Date:  1971-01       Impact factor: 5.209

8.  Surgical repair of complete transposition of the great arteries with pulmonary stenosis.

Authors:  G R Daicoff; G L Schiebler; L P Elliott; L H Van Mierop; T D Bartley; I H Gessner; M W Wheat
Journal:  Ann Thorac Surg       Date:  1969-06       Impact factor: 4.330

9.  A new approach to "anatomic" repair of transposition of the great arteries.

Authors:  G C Rastelli
Journal:  Mayo Clin Proc       Date:  1969-01       Impact factor: 7.616

10.  The tilted left anterior oblique position in the study of congenital cardiac anomalies.

Authors:  F A Puyau; H Burko
Journal:  Radiology       Date:  1966-12       Impact factor: 11.105

View more
  2 in total

1.  Double outlet right ventricle. Cross sectional echocardiographic findings, their anatomical explanation, and surgical relevance.

Authors:  F J Macartney; M L Rigby; R H Anderson; J Stark; N H Silverman
Journal:  Br Heart J       Date:  1984-08

2.  Successful implantation of a decellularized equine pericardial patch into the systemic circulation.

Authors:  Pascal Maria Dohmen; Francisco da Costa; Sergio Vega Lopes; Ricardo Vilani; Oliver Bloch; Wolfgang Konertz
Journal:  Med Sci Monit Basic Res       Date:  2014-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.